Secukinumab treatment demonstrated high drug survival and sustained effectiveness in patients with severe chronic plaque psoriasis: 21‐month analysis in Australian routine clinical practice (SUSTAIN study). - Foley, Peter; Manuelpillai, Nick; Dolianitis, Con; Cains, Geoffrey D.; Mate, Eric; Tronnberg, Rebecca; Baker, Christopher (Australasian Journal of Dermatology, 2022)